Drug Calibration Patents Under Scrutiny As Supreme Court Weighs How To Build On Law Of Nature
This article was originally published in The Pink Sheet Daily
Executive Summary
During oral arguments in Mayo v. Prometheus, justices question what standard to apply in assessing whether the correlation of a drug’s metabolites to proper dosage is patentable; ACLU petitions court to review Myriad gene patent case.